Health economic data in reimbursement of new medical technologies: importance of the socio-economic burden as a decision-making criterion
Background: Assessment and appraisal of new medical technologies require a balance between the interests of different stakeholders. Final decision should take into account the societal value of new therapies.Objective: This perspective paper discusses the socio-economic burden of disease as a specif...
Saved in:
Main Authors: | Georgi Iskrov (Author), Svetlan Dermendzhiev (Author), Tsonka Miteva-Katrandzhieva (Author), Rumen Stefanov (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multi-criteria decision analysis for assessment and appraisal of orphan drugs
by: Georgi Iskrov, et al.
Published: (2016) -
Socio-Economic Burden of Myasthenia Gravis: A Cost-of-Illness Study in Bulgaria
by: Valentina Ignatova, et al.
Published: (2022) -
Whole-Genome Sequencing in Newborn Screening-Attitudes and Opinions of Bulgarian Pediatricians and Geneticists
by: Georgi Iskrov, et al.
Published: (2017) -
Prospects of risk-sharing agreements for innovative therapies in a context of deficit spending in Bulgaria
by: Georgi eIskrov, et al.
Published: (2015) -
Challenges in mapping European rare disease databases, relevant for ML-based screening technologies in terms of organizational, FAIR and legal principles: scoping review
by: Ralitsa Raycheva, et al.
Published: (2023)